Cellular milieu imparts distinct pathological α-synuclein strains in α-synucleinopathies-Reference-Cited by-同舟云学术

Cellular milieu imparts distinct pathological α-synuclein strains in α-synucleinopathies

Published:2018-05 Issue:7706 Volume:557 Page:558-563
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Peng Chao,Gathagan Ronald J.,Covell Dustin J.,Medellin Coraima,Stieber Anna,Robinson John L.,Zhang Bin,Pitkin Rose M.,Olufemi Modupe F.,Luk Kelvin C.,Trojanowski John Q.,Lee Virginia M.-Y.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41586-018-0104-4.pdf

Reference35 articles.

1. Lippa, C. F. et al. Lewy bodies contain altered α-synuclein in brains of many familial Alzheimer’s disease patients with mutations in presenilin and amyloid precursor protein genes. Am. J. Pathol. 153, 1365–1370 (1998).

2. Spillantini, M. G. et al. α-Synuclein in Lewy bodies. Nature 388, 839–840 (1997).

3. Tu, P. H. et al. Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble α-synuclein. Ann. Neurol. 44, 415–422 (1998).

4. Bousset, L. et al. Structural and functional characterization of two α-synuclein strains. Nat. Commun. 4, 2575 (2013).

5. Guo, J. L. et al. Distinct α-synuclein strains differentially promote tau inclusions in neurons. Cell 154, 103–117 (2013).

Cited by 449 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Different neurotoxicity and seeding activity between α-synuclein oligomers formed in plasma of patients with Parkinson’s disease and multiple system atrophy;Neuroscience;2024-10

2. α-Synuclein strain propagation is independent of cellular prion protein expression in a transgenic synucleinopathy mouse model;PLOS Pathogens;2024-09-12

3. Chitosan‐enhanced sensitivity of mercaptoundecanoic acid (MUA)‐ capped gold nanorod based localized surface plasmon resonance (LSPR) biosensor for detection of alpha‐synuclein oligomer biomarker in parkinson’s disease;Biotechnology and Applied Biochemistry;2024-09-03

4. Rapid iPSC inclusionopathy models shed light on formation, consequence, and molecular subtype of α-synuclein inclusions;Neuron;2024-09

5. Lipids and α-Synuclein: adding further variables to the equation;Frontiers in Molecular Biosciences;2024-08-12